Fertility warning
This medicine may affect fertility.
Leaflet IDARUBICINA ACCORD 20mg / 20ml solution for injection
- Product code:
- W66329001
- Quantity:
- 1
- Indicated for:
- leukemia
- Route of administration:
- injectable
- Substance:
- idarubicin (antineoplastic agent)
- ATC
- L01DB06 — Antineoplastic and immunomodulating agents | Cytotoxic antibiotics and related substances | Anthracyclines and related substances
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Idarubicin is a chemotherapy drug used for the treatment of acute leukemia, including acute myeloid leukemia (AML). It belongs to the anthracycline class and works by inhibiting DNA synthesis in cancer cells, thereby preventing cell division.
The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for adverse effects during treatment.
Side effects may include nausea, vomiting, hair loss, bone marrow suppression, or cardiac toxicity. In rare cases, severe allergic reactions may occur.
Idarubicin is not recommended for patients with severe cardiac insufficiency, severe bone marrow suppression, or hypersensitivity to anthracyclines.
The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for adverse effects during treatment.
Side effects may include nausea, vomiting, hair loss, bone marrow suppression, or cardiac toxicity. In rare cases, severe allergic reactions may occur.
Idarubicin is not recommended for patients with severe cardiac insufficiency, severe bone marrow suppression, or hypersensitivity to anthracyclines.
General data about IDARUBICINA ACCORD 20mg / 20ml
- Substance:
- idarubicin
- Date of latest medicines list:
- 01-12-2019
- Product code:
- W66329001
- Concentration:
- 20mg / 20ml
- Pharmaceutical form:
- solution for injection
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for idarubicin
Concentrations available for idarubicin
- 10mg
- 10mg/10ml
- 20mg/20ml
- 5mg
- 5mg/5ml